Lékařem za hranicemi moderní medicíny

MUDr. Jan Trachta

Urol. praxi. 2019;20(1):3  

Use of botulinum toxin in paediatric urology

MUDr. Pavel Zerhau, CSc., MUDr. Matej Husár

Urol. praxi. 2019;20(1):9-12 | DOI: 10.36290/uro.2019.040  

Lower urinary tract dysfunction in children is very often connected with reduced compliance and urinary bladder hyperactivity.The treatment is conservative, moreover surgical in extreme cases. Endoscopic intravesical botulinum toxin application as miniinvasivetherapy occur among them. It represents safe and efficient treatment leading to continence increase, lower occurrenceof uninhibited contraction and urodynamic status improvement.

Pharmacological prophylaxis of bleeding in urological procedures

MUDr. Michal Balík, MUDr. Jaroslav Pacovský, Ph.D.

Urol. praxi. 2019;20(1):13-18 | DOI: 10.36290/uro.2019.041  

The rising number of urological procedures and the increasing age and morbidity of urologic patients increase the risk of perioperativebleeding complications. There is no simple recommendation to prevent bleeding. It should be based on the current stateof the patient, who undergo the specific urological procedure. Often, consultation with a specialist (hematologist or angiologist)is useful. In this paper we present an overview of the current possibilities of pharmacological prophylaxis of bleeding duringurological procedures.

Hematospermia

doc. MUDr. Jozef Marenčák, PhD.

Urol. praxi. 2019;20(1):19-24 | DOI: 10.36290/uro.2019.001  

Hematospermia, or hemospermia (HS), is defined by the presence of blood in ejaculate. It is usually an isolated symptom; however, it can present in association with hematuria, dysuria, and/ or scrotal pain. It often invokes considerable anxiety and is frightening to the patient. A single episode of HS is usually considered benign and the risk of malignancy is low. HS remains a symptom that is difficult to treat, especially if it is recurrent or persistent in nature. The patient´s age, recurrens of HS, and associated urinary symptoms, e.g. hematuria, can influence decisions for further diagnostic evaluation of affected man. A complete history, physical...

Have we found an optimal sequence in the treatment of metastatic castrationally-resistant prostate cancer?

MUDr. Tomáš Svoboda, Ph.D.

Urol. praxi. 2019;20(1):25-31  

Growing incidency of prostate cancer introduce a very important socioeconomic problem. Some patient proportion will develop dinase progression or relace and it´s androgen deprivation treatment successively fail while the tumor pass into castration resistent phase. At present, two main and basic treatment methods can be used in this situation – paliative chemotherapy by docetaxel or cabazitaxel and modern androgen receptor targeted agents treatment (ARTA) in the form of abirateron acetate (AA) or enzalutamide. Targeted alpha therapy, i.e. radium-223, can be sequenced if chemotherapy or ARTA treatment can not be used for some reason. The current...

Specifics of medical care in urology and andrology for LGBT community

MUDr. Pavel Turčan

Urol. praxi. 2019;20(1):32-35 | DOI: 10.36290/uro.2019.043  

At present, there is a growing openness to the existence of a gay, lesbian and transgender community (LGBT), and many peopleare not afraid of publicly acknowledging their orientation. Given that medical care for this part of the population differs in somefactors, we present in this article an overview of the most notable differences. We strive to provide information in such a way asto be beneficial to common practice and to assist doctors in the preventive and curative care of these patients.

Duplex synchronous unilateral uretero-arterial fistula as a cause of haematuria

MUDr. František Cmorej, MUDr. Erik Chorvát

Urol. praxi. 2019;20(1):36-39 | DOI: 10.36290/uro.2019.044  

We present a rare case report of duplex synchronous unilateral uretero-arterial fistula in young oncology woman patient withdifficult diagnosis process and state-of-the-art solutions of it.

Inflammatory myofibroblastic tumor

MUDr. Veronika Marcináková, MUDr. Hana Dittrichová, MUDr. Karel Franěk, MUDr. Pavel Hanek

Urol. praxi. 2019;20(1):40-41 | DOI: 10.36290/uro.2019.045  

We report a case of an uncommon malignancy of the urinary bladder in a 42-year-old male, removed via transurethral resection.Inflammatory myofibroblastic tumor, a neoplasm of uncertain malignant potential, is characterised by spindle myoepithelial cellproliferation and rich lymphocytic infiltrate. Disease occurs in internal organs and soft tissues of any body location. Diagnosticsis based on histologic examination, immunostaing and genetic mapping, which can help to identify typical genetic aberrations.The treatment of choice is complete surgical resection. The overall prognosis is good.

Presterilization preparation and care of flexible endoscopes in a urological practice

Johana Havránková, DiS., Bc. Xenie Šejvlová, Bc. Pavla Dvorská

Urol. praxi. 2019;20(1):42-45 | DOI: 10.36290/uro.2019.046  

The article provides general information on endoscopies. It deals in more detail with the care of flexible endoscopes with a particularfocus on handling flexible cystoscopes in a urological practice. Attention is also paid to machine washing and disinfectionof flexible cystoscopes.

Zpráva z pracovní konference SAU v Brně 23. a 24. listopadu 2018

MUDr. Michaela Matoušková

Urol. praxi. 2019;20(1)